Gainers & Losers
Mon Jul 14 2025 09:59:54- Titan Company share price
- ₹3,400.101.23%
- Indusind Bank share price
- ₹866.650.93%
- Itc share price
- ₹419.300.54%
- Sun Pharmaceutical Industr...
- ₹1,681.450.54%
- Mahindra And Mahindra share price
- ₹3,090.900.52%
Active Stocks
Mon Jul 14 2025 10:23:53- Reliance Industries share price
- ₹1,484.60-0.69%
- Icici Bank share price
- ₹1,422.600.03%
- Power Grid Corporation Of ...
- ₹298.20-0.13%
- Oil And Natural Gas Corp share price
- ₹244.301.01%
- Zee Entertainment Enterpri...
- ₹143.004.08%
Business News/Market/Market Stats/Divis Laboratories share price/ Divis Laboratories Profit Loss Annual
Divis Laboratories Profit & Loss Annual
6,790.00 -43.10 (-0.63%)Updated : 14 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 6,620.00 | 6,014.00 | 5,741.74 | 5,387.35 |
| Other Net | 304.00 | 0.00 | 4.84 | 3.68 |
| Diluted Weighted Average Shares | 26.55 | 26.55 | 26.55 | 26.55 |
| Depreciation/ Amortization | 401.00 | 378.00 | 343.18 | 311.51 |
| Operating Income | 2,578.00 | 1,831.00 | 2,025.77 | 3,572.48 |
| Net Income | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| Income Availableto Com Excl Extra Ord | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| Other Operating Expenses Total | 1,332.00 | - | - | - |
| Net Income Before Taxes | 2,929.00 | 2,163.00 | 2,368.63 | 3,683.50 |
| Net Income After Taxes | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| Income Availableto Com Incl Extra Ord | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| Costof Revenue Total | 3,677.00 | 3,759.00 | 3,688.79 | 3,489.23 |
| Gross Profit | 5,521.00 | 4,086.00 | 4,078.72 | 5,470.60 |
| Interest Inc( Exp) Net- Non- Op Total | 47.00 | 336.00 | 339.15 | 109.39 |
| Diluted Net Income | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| DPS- Common Stock Primary Issue | 30.00 | 30.00 | 30.00 | 30.00 |
| Provisionfor Income Taxes | 720.00 | 563.00 | 545.25 | 723.05 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 2,209.00 | 1,600.00 | 1,823.38 | 2,960.45 |
| Total Revenue | 9,198.00 | 7,845.00 | 7,767.51 | 8,959.83 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 9,198.00 | 7,845.00 | 7,767.51 | 8,959.83 |
| Selling/ General/ Admin Expenses Total | 1,210.00 | 1,811.00 | 1,654.40 | 1,541.48 |
| Diluted Normalized EPS | 83.20 | 60.38 | 68.72 | 111.58 |
| Diluted EPS Excluding Extra Ord Items | 83.20 | 60.27 | 68.69 | 111.52 |
| Gain( Loss)on Saleof Assets | - | -4.00 | -1.13 | -2.05 |
| Research Development | - | 66.00 | 55.37 | 45.13 |
*All figures in crores except per share values
Divis Laboratories Quick Links
Divis Laboratories Dividend Divis Laboratories Bonus Divis Laboratories News Divis Laboratories AGM Divis Laboratories Rights Divis Laboratories Splits Divis Laboratories Board Meetings Divis Laboratories Key Metrics Divis Laboratories Shareholdings Divis Laboratories Balance Sheet Divis Laboratories Cashflow Divis Laboratories Q1 Results Divis Laboratories Q2 Results Divis Laboratories Q3 Results Divis Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,400.10+41.15(1.23%)
866.65+7.95(0.93%)
419.30+2.25(0.54%)
2,401.00-38.60 (-1.58%)
1,578.15-24.85 (-1.55%)